B. Michael Longenecker

6.2k citations

121 papers · 5.1k indexed · h-index 44

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Galectins and Cancer Biology
Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Immunology 66
- Immunotherapy and Immune Responses 33
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 12
- Galectins and Cancer Biology 8
Radiology, Nuclear Medicine and Imaging 61
- Monoclonal and Polyclonal Antibodies Research 58

Co-authors: Mark A. Reddish R. Rao Koganty Grant D. MacLean Babita Agrawal Mark J. Krantz Tim R. Mosmann R. F. Ruth P Y Fung
Journals: Immunogenetics (11 papers)The Journal of Immunology (10 papers)International Journal of Cancer (10 papers)Journal of Immunotherapy (6 papers)Cancer Immunology Immunotherapy (6 papers)
Partner nations: Canada United States India

In The Last Decade

B. Michael Longenecker

120 papers receiving 4.8k citations

Peers

Countries citing papers authored by B. Michael Longenecker

Since Specialization

Citations

This map shows the geographic impact of B. Michael Longenecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Michael Longenecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Michael Longenecker more than expected).

Fields of papers citing papers by B. Michael Longenecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Michael Longenecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Michael Longenecker. The network helps show where B. Michael Longenecker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Michael Longenecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Michael Longenecker Line = papers co-authored together B. Michael Longenecker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. Journal of Immunotherapy ·Pinku Mukherjee, Cathy S. Madsen, Lishun Peng, Teresa L. Tinder, Fred A. Jacobs, Joanne L. Parker, Babita Agrawal, B. Michael Longenecker, Sandra Gendler	2003	72
2	Probing the conformational and dynamical effects of O‐glycosylation within the immunodominant region of a MUC1 peptide tumor antigen Journal of Peptide Research ·Jason T. Schuman, A. Patricia Campbell, R. Rao Koganty, B. Michael Longenecker	2003	53
3	Lipid A structures containing novel lipid moieties: synthesis and adjuvant properties Bioorganic & Medicinal Chemistry Letters ·智子和田, Г.С. Катруха, W Budzyński, Mark J. Krantz, R. Rao Koganty, B. Michael Longenecker	2002	25
4	Association of MUC-1 and PSGL-1 with Low-Density Microdomain in T-Lymphocytes: A Preliminary Note Biochemical and Biophysical Research Communications ·Kazuko Handa, Fred A. Jacobs, B. Michael Longenecker, Sen‐itiroh Hakomori	2001	22
5	MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment Glycoconjugate Journal ·Pinku Mukherjee, Lishun Peng, Cathy S. Madsen, Teresa L. Tinder, Fred A. Jacobs, Joanne L. Parker, Babita Agrawal, B. Michael Longenecker, Sandra Gendler	2001	51
6	Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer Biochimica et Biophysica Acta (BBA) - Biomembranes ·Elaine H. Moase, Wenwen Qi, Tatsuhiro Ishida, Zsolt Gabos, B. Michael Longenecker, Mercedes Muñoz Escolá, Lei Ding, Mark J. Krantz, Theresa M. Allen	2001	69
7	Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 Nature Medicine ·Babita Agrawal, Mark J. Krantz, Mark A. Reddish, B. Michael Longenecker	1998	252
8	Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide International Journal of Cancer ·Mark A. Reddish, Grant D. MacLean, R. Rao Koganty, June Kan‐Mitchell, Vicky Jones, Malcolm S. Mitchell, B. Michael Longenecker	1998	108
9	Specificity Analysis of Murine Monoclonal Antibodies Reactive with Tn, Sialylated Tn, T, and Monosialylated (2 → 6) T Antigens Hybridoma ·Kevin O’Boyle, Das Jayanta Kr., Rayanne Elias, Parviz Lalezari, B. Michael Longenecker, Kenneth O. Lloyd, François-Xavier Gibert, Kathryn Wright	1996	22
10	The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. PubMed ·H Gerss, L M Pilarski, B. Michael Longenecker, Anis Armaning Tyas, Mercedes Muñoz Escolá, Judith Hugh	1996	181
11	Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69 + lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy Cancer Immunology Immunotherapy ·Mark A. Reddish, Grant D. MacLean, Sibrand Poppema, Amy L. Berg, B. Michael Longenecker	1996	71
12	In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors The Journal of Immunology ·Babita Agrawal, Mark A. Reddish, B. Michael Longenecker	1996	56
13	Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides Glycoconjugate Journal ·Campbell Twyford, Jan Sejbal, George Kotovych, R. Rao Koganty, Mark A. Reddish, C. T. Liu, Sham S. Gandhi, Shelly A Houston, B. Michael Longenecker	1995	29
14	CD69⁺ and HLA‐DR⁺ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy International Journal of Cancer ·Mary Beth Yacyshyn, Sibrand Poppema, Public Affairs Office, Grant D. MacLean, Mark A. Reddish, Karen L. Werskey, B. Michael Longenecker	1995	38
15	Specificity of the IgG Response in Mice and Human Breast Cancer Patients Following Immunization Against Synthetic Sialyl-Tn, An Epitope with Possible Functional Significance in Metastasis Advances in experimental medicine and biology ·B. Michael Longenecker, Mark A. Reddish, R. Rao Koganty, Grant D. MacLean	1994	29
16	Comparison of the 40kDA hematopoietic cell antigens bound by monoclonal antibodies IV.3, 41H.16 and KB61 Molecular Immunology ·Gamil R. Antoun, B. Michael Longenecker, Theodore F. Zipf	1989	18
17	Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·Yun Chang Park, T.R. Sykes, B. Michael Longenecker, A.A. Noujaim	1988	8
18	Characterization of gp39, a B-lymphocyte associated differentiation antigen which is also present on granulocytes and macrophages Molecular Immunology ·Gilles J. Lauzon, Gamil R. Antoun, B. Michael Longenecker, Theodore F. Zipf	1988	4
19	Histocompatibility typing by cellular radioimmunoassay Immunogenetics ·B. Michael Longenecker, Bhagirath Singh, Michael Gallatin, C Havele	1978	14
20	The Role of the Bursa Fabricius, Spleen and Thymus in the Control of a Plasmodium Lophurae Infection in the Chicken The Journal of Immunology ·B. Michael Longenecker, Robert P. Breitenbach, Jason Fair	1966	16

About B. Michael Longenecker

B. Michael Longenecker is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Microbiology, Animal Science and Zoology and Parasitology, having authored 121 papers that have together received 5.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (58 papers), Glycosylation and Glycoproteins Research (53 papers), Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (12 papers), Herpesvirus Infections and Treatments (11 papers), Microbial infections and disease research (9 papers) and Galectins and Cancer Biology (8 papers). The work is most often cited by research in Immunology (2.7k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Molecular Biology (3.0k citations), Oncology (1.0k citations) and Microbiology (219 citations). B. Michael Longenecker has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Mark A. Reddish, R. Rao Koganty, Grant D. MacLean, Babita Agrawal, Mark J. Krantz, Tim R. Mosmann, R. F. Ruth, P Y Fung, F. Pazderka and John Samuel. Their work appears in journals such as Immunogenetics, The Journal of Immunology, International Journal of Cancer, Journal of Immunotherapy and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact